Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine
Not Applicable
Recruiting
- Conditions
- SchizophreniaClozapineExercise
- Registration Number
- NCT06573320
- Lead Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion Criteria:<br><br> - Patients treated who were diagnosed with schizophrenia according to DSM-V criteria<br> by psychiatrist at the Turkish Ministry of Health Kartal Dr. Lütfi Kirdar City<br> Hospital<br><br> - using a therapeutic dose of 300-500 mg/day of clozapine,<br><br>Exclusion Criteria:<br><br> - pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Montreal Cognitive Assessment (MOCA);Positive and Negative Syndrome Scale (PANSS)
- Secondary Outcome Measures
Name Time Method